Document is current
Any future updates will be listed below
-
Authors
Kameda, Hideto https://orcid.org/0000-0002-4330-5782
Maezawa, Reina
Minegishi, Yasuto
Imaizumi, Chihiro
Katagiri, Takaharu
Ogura, Takehisa
- License Information
-
More Information
Article History
Received: 9 April 2025
Accepted: 24 August 2025
First Online: 5 September 2025
Declarations
:
: None.
: H.K. received consulting and/or speaker fees from AbbVie, Asahi Kasei, Bristol-Myers Squibb, Eisai, Eli Lilly, Janssen, Mitsubishi Tanabe, and UCB and research/educational grants from Asahi Kasei, Pfizer, and Taisho. The other authors have nothing to declare in relation to this manuscript.
: Ethics approval was waived because of the nature of this manuscript.
: Not applicable.
: All the authors provided final approval for the version to be published and agreed to be accountable for all aspects of the work.
: Not applicable.
: Not applicable.
: Hideto Kameda: conception and drafting of the work; Reina Maezawa, Yasuto Minegishi, Chihiro Imaizumi, Takaharu Katagiri, and Takehisa Ogura: interpretation of data for the work and reviewing the work critically for important intellectual content.
